Formation Bio
👥
Possible contacts at Formation Bio.
| Title | Name |
|---|---|
| CEO & Co-Founder | Ben Liu |
|
Formation Bio Business Breakdown & Founding Story
contrary.com https://research.contrary.com › company › formation-bio
• May 1, 2025
Formation Bio is a tech-enabled drug development company. It addresses the clinical trials bottleneck in the drug development process.
Business
company
|
|
Leveraging AI to Streamline Clinical Development, with ...
The Conference Forum https://theconferenceforum.org › editorial › leveraging-...
• May 28, 2025
Dr Gavin Corcoran, Chief Development Officer of Formation Bio discusses where AI can positively impact clinical development and investing in AI solutions.
Business
|
|
Formation Bio: 2025 CNBC Disruptor 50
CNBC https://www.cnbc.com › 2025/06/10 › formation-bio-c...
• Jun 10, 2025
Formation Bio is disrupting the traditional approach to drug development and commercialization, using automation and generative AI to ...
Business
More |
|
Formation Bio - Products, Competitors, Financials ...
CB Insights https://www.cbinsights.com › company › trialspark
Formation Bio focuses on improving drug development within the pharmaceutical industry. The company specializes in acquiring clinical-stage assets.
Business
company
More |
|
Formation Bio
LinkedIn · Formation Bio 39.7K+ followers
Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development.
Business
company
More |
|
Formation Bio Announces First Class of Entrepreneurs in ...
PR Newswire https://www.prnewswire.com › news-releases › formation...
• Jun 9, 2025
Formation Bio, an AI-driven pharmaceutical company focused on accelerating drug development, today announced the appointment of its first class of ...
News
company focused
recent
More |
|
Formation Bio Licenses First-in-Class Anti-CD226 ...
PR Newswire https://www.prnewswire.com › news-releases › formation...
• Jul 29, 2025
Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. Formation Bio has built technology and ...
News
company
recent
initiative
More |
|
Formation Bio Licenses Gusacitinib to Sanofi
Contract Pharma https://www.contractpharma.com › Breaking News
• Jun 23, 2025
Gusacitinib was acquired by Formation Bio in late 2022 from Asana BioSciences as part of a broader portfolio of investigational medicines. This ...
News
recent
|
|
Press Release: Sanofi, Formation Bio and OpenAI ...
Sanofi https://www.sanofi.com › media-room › press-releases
• May 21, 2024
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024.
News
New
recent
More |
|
CNBC Disruptor 50: Formation Bio CEO Benjamine Liu on ...
CNBC https://www.cnbc.com · Jun 10, 2025
Formation Bio uses Ai and automation to more efficiently bring drugs to Market by redesigning the steps in the process from R&D strategy to clinical trials.
Program
More |